glp 1 blue cross Prime Therapeutics' leading research shows only in 12 remain on a GLP-1 drug for obesity at three years Blue Cross Blue Shield plans

But we are not mentioning that it's, we're telling people not to use it for, once you open the bottle, use it within three months

Heres what I think it signals for the broader market: - Pricing pressure on branded players (Lilly, Novo)

Sleep, Stress, Hormones, and Medications May Be Interfering Weight loss can be affected by sleep apnea, poor sleep quality, chronic stress, cortisol patterns, thyroid function, menopause, low testosterone, insulin resistance, certain antidepressants, steroids, beta blockers, and other medications or health conditions

Body Odor: A distinctive fishy body odor has been reported by some users

PMID: 37 YanHWangLZhangGLiNZhaoYLiuJet al

Cost and patient reluctance toward injectables pose significant restraints to market growth